GlassScriptPhysician profile
Thomas R Lux
NPI 1003834409
$2,473.71
in general payments reported to CMS, 2019-2025
32 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $150 · 2022: $41.65 · 2023: $739 · 2024: $344 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.58 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $441.85 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $331.67 | 2023-2025 | |
| Pfizer INC. | $260.70 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $233.19 | 2019-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $123.19 | 2023-2024 | Arexvy, Shingrix, Fluarix Quadrivalent |
| Astellas Pharma US INC | $115.29 | 2019-2023 | |
| Lilly USA, LLC | $99.38 | 2022-2025 | Mounjaro, Emgality, Jardiance |
| Radius Health, INC. | $92.13 | 2024-2025 | Tymlos |
| Stimwave Technologies Incorporated | $91.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.14 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $69.98 | 2019-2020 | |
| Abbott Laboratories | $59.54 | 2023-2024 | Freestyle Libre |
| Allergan, INC. | $48.86 | 2020 | |
| Merck Sharp & Dohme LLC | $47.05 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $45.14 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $40.64 | 2025 | Edarbi, Alvesco |
| Amgen INC. | $39.49 | 2019-2025 | Evenity |
| Novartis Pharmaceuticals Corporation | $33.02 | 2019 | |
| Idorsia Pharmaceuticals US INC | $29.41 | 2023 | Quviviq |
| Inspire Medical Systems, INC. | $23.29 | 2023 | Inspire |
| Ibsa Pharma INC. | $18.07 | 2025 | Flector, Licart, Tirosint |
| Genentech USA, INC. | $16.59 | 2019 | |
| Exact Sciences Corporation | $15.69 | 2023 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $15.35 | 2019 | |
| Esperion Therapeutics, INC. | $15.16 | 2025 | Nexletol |
| Amarin Pharma, INC. | $14.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.75 | 2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $14.10 | 2024 | Livalo |
| Scilex Pharmaceuticals INC. | $13.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.85 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.